Patent · US Active

Mammalian cell line for protein production and library generation

US11802281B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 2017
Grant dateOct 31, 2023
Priority date
Expiry dateOct 25, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2521/539
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

According to a first aspect of the invention, a method for the generation of a cell line is provided, comprising the steps of (a) providing a plurality of mammalian B cells, wherein each of the plurality of B cells comprises a transgenic genomic DNA sequence encoding a marker protein inserted into an endogenous immunoglobulin locus comprised in said B cell, and wherein the transgenic genomic DNA sequence is amenable to cleavage by a site directed nuclease, particularly Cas9; (b) replacing the transgenic genomic DNA sequence encoding a marker protein with a second transgenic DNA sequence encoding a protein of interest; (c) sorting B cells based on the presence or absence of the marker protein; and (d) collecting B cells in which the marker protein is absent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.